These data were similar to the TCGA breast cancer database (1247 patients), i.e., there was no significant difference in survival between ABCB1 polymorphism carriers (both alleles mutated) and non-carriers (wild-types and heterozygotes) (Figure 2A). Here, ABCB1 is linked to breast carcinoma.